VP, GPL Franchise Lead – HCT (Hematology and Cell Therapy)

Bristol Myers Squibb

18d

About The Position

Working with Us Challenging. Meaningful. Life-changing. Those aren’t words that are usually associated with a job. But working at Bristol Myers Squibb is anything but usual. Here, uniquely interesting work happens every day, in every department. From optimizing a production line to the latest breakthroughs in cell therapy, this is work that transforms the lives of patients, and the careers of those who do it. You’ll get the chance to grow and thrive through opportunities uncommon in scale and scope, alongside high-achieving teams. Take your career farther than you thought possible. Bristol Myers Squibb recognizes the importance of balance and flexibility in our work environment. We offer a wide variety of competitive benefits, services and programs that provide our employees with the resources to pursue their goals, both at work and in their personal lives. Read more: careers.bms.com/working-with-us. Position Title: VP, GPL Franchise Lead – HCT (Hematology and Cell Therapy) Position Summary: Accountable for maximizing the value of the HCT portfolio by shaping the end-to-end disease strategy, in partnership with Research, Development, Global Product Development & Supply (GPS), and Commercialization, and leading a team of Global Program Leads to translate those strategies into efficient execution. This role reports to the SVP, Head of HOCT Development with matrix reporting to the SVP, Drug Development Strategy & Portfolio Management

Requirements

• MD, PhD, DVM, PharmD, or equivalent advanced degree of relevance
• 10+ years of experience in the drug development process and leadership experience in academic or industry settings, including education where applicable
• Expertise in the drug development process, especially late development space, relevant regulatory expectations, and overall drug development principles
• Proven leadership capability building high-performing teams, managing large organizations and matrix teams with a successful track record of leading through influence and working across global organizational matrices
• Deep understanding of basic biology, pharmaceutical optimization, translational medicine, and clinical pharmacology, including exposure-response relationships and dose selection in early development
• Working knowledge of all functional areas of exploratory development (e.g., chemistry/biochemistry, CMC), late development, and commercial
• Ability to create a clear purpose, global vision, strategies, and key priorities for competing successfully in the evolving pharmaceutical and healthcare industry
• Demonstrated ability to lead a cross-functional team to execute Development Plans which have a global perspective and focus on product differentiation, including opportunities for data-driven acceleration
• Demonstrated ability to assess complex but relatively sparse data sets objectively, make informed decisions and take action in the face of uncertainty
• Demonstrated ability to successfully present complex programs to senior leaders and influence decision making
• Demonstrated ability to successfully and effectively communicate, collaborate and work across functional boundaries
• Strong business and financial acumen to ensure portfolio strategies and investment decisions help accelerate company goals

Responsibilities

• Develops Disease Area Portfolio Strategy: Set the end-to-end disease strategy spanning the full lifecycle in partnership with drug development functions (including Strategy & Portfolio Management, global regulatory & safety, and global development operations), and other functions (including research, commercialization, GPS, and enterprise strategy)
• Accelerate the portfolio and reduce development timelines for most promising new assets, while optimizing the revenue and reach of currently marketed products
• Lead all R&D business development activities for the Immunology and Cardiovascular portfolio, in partnership with the Business Development team and DD Strategy & Portfolio Management
• Effectively manages disease portfolio budget, making tradeoff decisions with enterprise mindset
• Drives execution of portfolio strategy through leadership of Disease Area Global Program Leads: Leads and inspires a high-performing organization of Global Program Leaders (GPLs) across the Disease Area
• Oversees orchestration of design and execution of globally integrated program strategies, timelines, and budgets from candidate nomination to successful launch, commercialization, and lifecycle management within Hematology and Cell Therapy.
• Prioritizes, synthesizes, and pressure tests feedback from senior leadership on program direction/outputs and coaches GPLs in building this skillset
• Provide strategic and technical leadership to build a world-class drug development team while enabling the balance between scientific excellence and operational effectiveness
• Demonstrate inspirational leadership to engage, develop, and create an inclusive/diverse environment that drives innovation
• Demonstrate superior enterprise mindset and leadership maturity to shape the future of R&D
• Ensures Program Leaders within the Disease Area demonstrate must-win capabilities and partner effectively with functions within R&D (e.g., Clinical Development) and across the Enterprise (e.g., Operations, GPS, Commercial)
• Engages senior leaders and functional area stakeholders to ensure alignment of program strategy and operational plans under the remit
• Clearly communicates program risks, implications of changes in the competitive landscape, and progress toward key milestones
• Leads team problem-solving in delivering key data and interpretation essential for robust debate and rapid, data-driven decision making
• Leverages experience to efficiently integrate information from team members and facilitate rapid and objective, data-driven decisions
• Leads team members to effectively engage cross-company expertise and utilize governance bodies to define asset development strategies and implementation plans
• Serves as Global Program Lead (GPL) for one or program: Acts as the “single point of accountability” for leading the Global Program Team (GPT) through the design and execution of a global integrated program strategy, overseeing all aspects of the drug development lifecycle to ultimately ensure successful launch and commercialization.
• Develops, leads, and inspires a high-performing matrix team and is responsible for ensuring strategic alignment with cross-functional stakeholders and senior leaders as data emerge and competitive insights unfold.

Benefits

• Health Coverage: Medical, pharmacy, dental, and vision care.
• Wellbeing Support: Programs such as BMS Well-Being Account, BMS Living Life Better, and Employee Assistance Programs (EAP).
• Financial Well-being and Protection: 401(k) plan, short- and long-term disability, life insurance, accident insurance, supplemental health insurance, business travel protection, personal liability protection, identity theft benefit, legal support, and survivor support.
• Work-life benefits include: Paid Time Off US Exempt Employees: flexible time off (unlimited, with manager approval, 11 paid national holidays (not applicable to employees in Phoenix, AZ, Puerto Rico or Rayzebio employees) Phoenix, AZ, Puerto Rico and Rayzebio Exempt, Non-Exempt, Hourly Employees: 160 hours annual paid vacation for new hires with manager approval, 11 national holidays, and 3 optional holidays Based on eligibility, additional time off for employees may include unlimited paid sick time, up to 2 paid volunteer days per year, summer hours flexibility, leaves of absence for medical, personal, parental, caregiver, bereavement, and military needs and an annual Global Shutdown between Christmas and New Years Day. All global employees full and part-time who are actively employed at and paid directly by BMS at the end of the calendar year are eligible to take advantage of the Global Shutdown.

What This Job Offers

• Job Type: Full-time
• Career Level: Executive
• Education Level: Ph.D. or professional degree